#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Gastric cancer Enteritis Congenital disorder of glycosylation Hereditary angioedema with C1 esterase inhibitor deficiency Hypoparathyroidism Essential thrombocythaemia Ventricular fibrillation Osteogenesis imperfecta Precursor T-lymphoblastic lymphoma/leukaemia recurrent Carcinoid tumour Lymphangiosarcoma Primary hyperoxaluria Haemolytic uraemic syndrome Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII Sjogren’s syndrome – Trials in Disease Ewing’s sarcoma metastatic Synovial sarcoma recurrent – Basic Information Nephroblastoma – Diagnostics Breast angiosarcoma metastatic – Treatment Pituitary-dependent Cushing’s syndrome – Treatment CADASIL Congenital hypotransferrinaemia – Treatment Chordoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pemafibrate Mirabegron Furosemide Levoleucovorin Disodium Maribavir Tinzaparin Defactinib Ceftolozane L-LEUCINE ATOVAQUONE Streptococcus Agalactiae Milademetan Ipn01194 Ro7269162 Odm-111 Botulinum Toxin Type A Specific Nucleic Acid Sna-Papi Neridronate Sodium Acetic Acid, Glacial Atezolizumab More therapies…

    Learn about Your Condition

    Hodgkin's disease recurrent Eyelid ptosis Haematological malignancy Combined immunodeficiency Metastasis Rheumatoid arthritis Pemphigus Acute cardiac event Polycystic liver disease Glucose tolerance impaired Renal disorder Malabsorption Hodgkin's disease refractory Strongyloidiasis Vulvovaginal discomfort More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on the Safety and Effectiveness of rAAV.hCNGA3 for Adults and Minors with CNGA3-Linked Achromatopsia

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Colour blindness
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 8 Containing The Human Cnga3 Gene Under The Control Of A Cone Arrestin Promoter
    Germany

  • Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    Bulgaria Czechia Denmark Germany Ireland Italy +1

  • Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

    Not recruiting

    3 1 1
    France Poland Portugal Spain

  • Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Graves’ disease
    Austria Czechia Germany Hungary Italy

  • Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Tenecteplase
    Germany

  • Study on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Ranibizumab
    Austria Germany
Previous Page
1 … 30 31 32 33 34 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!